BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33794268)

  • 21. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors.
    Dempsey KM; Broaddus R; You YN; Noblin SJ; Mork M; Fellman B; Urbauer D; Daniels M; Lu K
    Genet Med; 2015 Jun; 17(6):476-84. PubMed ID: 25341111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
    Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
    Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
    Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
    Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
    Latham A; Srinivasan P; Kemel Y; Shia J; Bandlamudi C; Mandelker D; Middha S; Hechtman J; Zehir A; Dubard-Gault M; Tran C; Stewart C; Sheehan M; Penson A; DeLair D; Yaeger R; Vijai J; Mukherjee S; Galle J; Dickson MA; Janjigian Y; O'Reilly EM; Segal N; Saltz LB; Reidy-Lagunes D; Varghese AM; Bajorin D; Carlo MI; Cadoo K; Walsh MF; Weiser M; Aguilar JG; Klimstra DS; Diaz LA; Baselga J; Zhang L; Ladanyi M; Hyman DM; Solit DB; Robson ME; Taylor BS; Offit K; Berger MF; Stadler ZK
    J Clin Oncol; 2019 Feb; 37(4):286-295. PubMed ID: 30376427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
    Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
    Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of germline multi-gene panel testing in patients with endometrial cancer.
    Karpel HC; Chern JY; Smith J M; Smith A J; Pothuri B
    Gynecol Oncol; 2022 Jun; 165(3):546-551. PubMed ID: 35483985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lynch or not Lynch? Is that always a question?
    Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
    Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early detection of duodenal cancer by upper gastrointestinal-endoscopy in Lynch syndrome.
    Vangala DB; Ladigan-Badura S; Engel C; Hüneburg R; Perne C; Bucksch K; Nattermann J; Steinke-Lange V; Rahner N; Weitz J; Kloor M; Tomann J; Canbay A; Nguyen HP; Strassburg C; Möslein G; Morak M; Holinski-Feder E; Büttner R; Aretz S; Löffler M; Schmiegel W; Pox C; Schulmann K;
    Int J Cancer; 2021 Dec; 149(12):2052-2062. PubMed ID: 34331771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome.
    Kim J; Braun D; Ukaegbu C; Dhingra TG; Kastrinos F; Parmigiani G; Syngal S; Yurgelun MB
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):830-837.e1. PubMed ID: 31319185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.
    Lin KM; Shashidharan M; Thorson AG; Ternent CA; Blatchford GJ; Christensen MA; Watson P; Lemon SJ; Franklin B; Karr B; Lynch J; Lynch HT
    J Gastrointest Surg; 1998; 2(1):67-71. PubMed ID: 9841970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome.
    Cloyd JM; Chun YS; Ikoma N; Vauthey JN; Aloia TA; Cuddy A; Rodriguez-Bigas MA; Nancy You Y
    J Gastrointest Cancer; 2018 Mar; 49(1):93-96. PubMed ID: 29238914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
    Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA
    J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
    Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
    Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current clinical topics of Lynch syndrome.
    Tanakaya K
    Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.
    Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
    Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP
    Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.